Júlia Gaál-Weisinger

Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasms.

L. Reiniger, T. Masszi, C. Bödör, 2019, Pathology.

Beneficial Effect of Lenalidomide-Dexamethason Treatment in Relapsed/Refractory Multiple Myeloma Patients: Results of Real-Life Data From 11 Hungarian Centers

Z. Lengyel, Á. Illés, Z. Borbényi, 2021, Pathology & Oncology Research.

The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria.

J. Panse, M. Biedzka-Sarek, B. Klughammer, 2020, Blood.